Magnesium sulfate administration in subarachnoid hemorrhage

Neurocritical Care

Volumn 15, Issue 2, 2011, Pages 302-307

  Suarez, Jose I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Delayed cerebral ischemia; Infusion; Intravenous; Neuroprotection; Vasospasm

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; NIMODIPINE; PLACEBO; ANTICONVULSIVE AGENT; NEUROPROTECTIVE AGENT;

BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CONTINUOUS INFUSION; DELAYED BRAIN ISCHEMIA; DELAYED ISCHEMIC INFARCTION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ENDOVASCULAR ANEURYSM REPAIR; EVIDENCE BASED MEDICINE; EXTENDED GLASGOW OUTCOME SCALE; FACIAL FLUSHING; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GLASGOW OUTCOME SCALE; HEART FAILURE; HEART INFARCTION; HOT FLUSH; HUMAN; HYPOCALCEMIA; HYPOTENSION; KIDNEY FAILURE; LUNG EMBOLISM; MENINGITIS; MORTALITY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; VASOSPASM; ACUTE DISEASE; INTENSIVE CARE; METHODOLOGY;

ACUTE DISEASE; ANTICONVULSANTS; BRAIN ISCHEMIA; HUMANS; INTENSIVE CARE; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84855880825     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9603-y     Document Type: Review

References (23)

1. Saddeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke. 1989;20:1273-5.
2. Taccone FS. Vasodilation and neuroprotection: The magnesium saga in subarachnoid hemorrhage. Crit Care Med. 2010;38: 1382-3.
3. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intra-arterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996; 85:117-24. (Pubitemid 26195046)
4. van den Bergh WM, Dijkhuizen RM, Rnkel GJ. Potentials of magnesium treatment in subarachnoid hemorrhage. Magnes Res. 2004;17:301-13.
5. Ortega-Gutierrez S, Mayer SA. Is the magnesium era for aneurysmal subarachnoid hemorrhage over? Curr Neurol Neurosci Rep. 2010;10:420-2.
6. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
7. Wong GKC, Poon WS, Chan MTV, Boet R, Gin T, Ng SCP, Zee BCY, For the IMASH Investigators. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): A randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921-6.
8. Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study. Crit Care Med. 2010;38:1284-90.
9. Wong GKC, Chan MTV, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: A prospective randomized pilot study. J Neurosurg Anesthesiol. 2006;18:142-8. (Pubitemid 44510114)
10. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Stroke. 2005;36:1011-5. (Pubitemid 40629294)
11. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: A randomized study. Neurosurgery. 2006;58:1054-65.
12. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurismal subarachnoid hemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33-9. (Pubitemid 350181007)
13. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;96:510-4. (Pubitemid 34230205)
14. van den Bergh WM, Albrecht KW, Berkelbach JW, van der Sprenkel B, Rinkel GJE. Magnesium therapy after aneurysmal subarachnoid haemorrhage dose-finding study for long term treatment. Acta Neurochir. 2003;145:195-9. (Pubitemid 36359700)
15. Stippler M, Crago E, Levy EI, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg. 2006;105:723-9. (Pubitemid 44703935)
16. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery. 2000;47:602-7. (Pubitemid 32044706)
17. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO. Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2001;13: 202-6. (Pubitemid 32606414)
18. Mori K, Yamamoto T, Nakao Y, et al. Initial clinical experience of vasodilatory effect of intracisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2009;49: 139-45.
19. Friedlich D, Agner C, Boulos AS, et al. Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: A single center experience. Neurol Res. 2009;31:621-5.
20. Kerz T, Victor A, Beyer C, Trapp I, Heid F, Reisch R. A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: Incidence of delayed cerebral ischemia and mortality. Neurol Res. 2008;30:893-7.
21. Yahia AM, Kirmani JF, Qureshi AI, Guterman LR, Hopkins LN. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2005;3:16-23. (Pubitemid 41278388)
22. Shah QA, Memon MZ, Suri MFK, et al. Super-selective intraarterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11:190-8.
23. Barile M, van de Wyngaert F, Mbia JJE, et al. Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage. Intensive Care Med. 2003;29:1182-5. (Pubitemid 36918566)